research Safety Profile of Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors: A Disproportionality Analysis of FDA Adverse Event Reporting System 58 citations, March 2020 in “Scientific Reports” EGFR-TKIs can cause significant skin, nail, and organ side effects.